Grand Pharmaceutical Group Ltd (HKSE:00512) Share Price

Company Profile

Business description
Grand Pharmaceutical Group Ltd, is an international pharmaceutical company of technological innovation. Its core businesses cover three areas: nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, pharmaceutical technology, and biotechnology. Based on the pharmaceutical and biological industries, the Group focuses on the needs of patients, and technological innovation as the driving force Geographically, it derives a majority of its revenue from the PRC and also has a presence in America; Europe; and Asia other than the PRC, and others.
Contact
99 Queen's Road
Units 3302, 33rd Floor, The Center
Central
Hong Kong
HKG
https://www.grandpharma.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
12,440

Recommended

These three companies are trading at a significant premium to our fair value.

Morningstar | 08 September 2025

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.

Malik Ahmed Khan, CFA | 05 September 2025

A difficult year but better times ahead.

Johannes Faul, CFA | 05 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,126.90	2.50	-0.03%
CAC 40	7,699.16	24.38	0.32%
DAX 40	23,760.30	163.32	0.69%
Dow JONES (US)	45,400.86	220.43	-0.48%
FTSE 100	9,217.71	9.50	0.10%
HKSE	25,633.91	215.93	0.85%
NASDAQ	21,700.39	7.30	-0.03%
Nikkei 225	43,643.81	625.06	1.45%
NZX 50 Index	13,281.14	57.61	0.44%
S&P 500	6,481.50	20.58	-0.32%
S&P/ASX 200	8,849.60	5.60	-0.06%
SSE Composite Index	3,826.84	14.33	0.38%